437
Views
6
CrossRef citations to date
0
Altmetric
Phenotypes

Female-specific risk factors associated with risk of ACO (asthma COPD overlap) in aboriginal people

, MScORCID Icon, , MD, , PhD & , MD, PhDORCID Icon
Pages 925-932 | Received 18 Feb 2019, Accepted 16 May 2019, Published online: 05 Jun 2019

References

  • Global Initiative for Asthma (GINA). The Global Strategy for Asthma Management and Prevention. 2014.
  • Koleade A, Farrell J, Mugford G, Gao Z. Prevalence and risk factors of ACO (asthma-COPD overlap) in aboriginal people. J Environ Public Health. 2018;2018:1. doi:10.1155/2018/4657420.
  • Postma DS, Rabe KF. The asthma-COPD overlap syndrome. N Engl J Med. 2015;373:1241–1249. doi:10.1056/NEJMra1411863.
  • de Marco R, Marcon A, Rossi A, Antó JM, Cerveri I, Gislason T, Heinrich J, et al. Asthma, COPD and overlap syndrome: a longitudinal study in young European adults. Eur Respir J. 2015;46:671–679. doi:10.1183/09031936.00008615.
  • Tho NV, Park HY, Nakano Y. Asthma-COPD overlap syndrome (ACOS): a diagnostic challenge. Respirology. 2016;21:410–418. doi:10.1111/resp.12653.
  • Barrecheguren M, Esquinas C, Miravitlles M. The asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): opportunities and challenges. Curr Opin Pulm Med. 2015;21:74–79. doi:10.1097/MCP.0000000000000118.
  • Gerhardsson de Verdier M, Andersson M, Kern DM, Zhou S, Tunceli O. Asthma and chronic obstructive pulmonary disease overlap syndrome: doubled costs compared with patients with asthma alone. Value Health. 2015;18:759–766. doi:10.1016/j.jval.2015.04.010.
  • Kim M-A, Noh CS, Chang Y-J, Hong Y-K, Lee JS, Lee SW, Lee S-D, et al. Asthma and COPD overlap syndrome is associated with increased risk of hospitalisation. Int J Tuberc Lung Dis. 2015;19:864–869. doi:10.5588/ijtld.14.0327.
  • MacMillan HL, MacMillan AB, Offord DR, Dingle JL. Aboriginal health. CMAJ 1996;155:1569–1578.
  • Fraser-Lee NJ, Hessel PA. Acute respiratory infections in the Canadian native Indian population: a review. Can J Public Health. 1994;85:197–200.
  • Cadeddu C, Capizzi S, Colombo D, Nica M, De Belvis AG. Literature review of gender differences in respiratory conditions: a focus on asthma and chronic obstructive pulmonary disease (COPD). Ig Sanita Pubbl. 2016;72:481–504.
  • Nicolini A, Barbagelata E, Tagliabue E, Colombo D, Monacelli F, Braido F. Gender differences in chronic obstructive pulmonary diseases: a narrative review. Panminerva Med. 2018;60:192–199. doi:10.23736/S0031-0808.18.03463-8.
  • Macsali F, Svanes C, Bjorge L, Omenaas ER, Gomez Real F. Respiratory health in women: from menarche to menopause. Expert Rev Respir Med. 2012;6:187–200. quiz 201-2. doi:10.1586/ers.12.15.
  • Smith JR, Emerson SR, Kurti SP, Gandhi K, Harms CA. Lung volume and expiratory flow rates from pre- to post-puberty. Eur J Appl Physiol. 2015;115:1645–1652. doi:10.1007/s00421-015-3149-1.
  • Zemp E, Schikowski T, Dratva J, Schindler C, Probst-Hensch N. Asthma and the menopause: a systematic review and meta-analysis. Maturitas. 2012;73:212–217. doi:10.1016/j.maturitas.2012.08.010.
  • Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non-smokers. Lancet. 2009;374:733–743. doi:10.1016/S0140-6736(09)61303-9.
  • Silverman EK, Weiss ST, Drazen JM, Chapman HA, Carey V, Campbell EJ, Denish P, et al. Gender-related differences in severe, early-onset chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;162:2152–2158. doi:10.1164/ajrccm.162.6.2003112.
  • Wheaton AG, Pleasants RA, Croft JB, Ohar JA, Heidari K, Mannino DM, Liu Y, et al. Gender and asthma-chronic obstructive pulmonary disease overlap syndrome. J Asthma. 2016;53:720–731. doi:10.3109/02770903.2016.1154072.
  • Prescott E, Bjerg AM, Andersen PK, Lange P, Vestbo J. Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study. Eur Respir J. 1997;10:822–827.
  • Pahwa P, Karunanayake CP, Rennie DC, Lawson JA, Ramsden VR, McMullin K, Gardipy PJ, et al. Prevalence and associated risk factors of chronic bronchitis in first nations people. BMC Pulm Med. 2017;17:95doi:10.1186/s12890-017-0432-4.
  • Langhammer A, Johnsen R, Holmen J, Gulsvik A, Bjermer L. Cigarette smoking gives more respiratory symptoms among women than among men. The Nord-Trondelag health study (HUNT). J Epidemiol Community Health. 2000;54:917–922. doi:10.1136/jech.54.12.917.
  • Ben-Zaken Cohen S, Pare PD, Man SF, Sin DD. The growing burden of chronic obstructive pulmonary disease and lung cancer in women: examining sex differences in cigarette smoke metabolism. Am J Respir Crit Care Med. 2007;176:113–120. doi:10.1164/rccm.200611-1655PP.
  • Almagro P, López García F, Cabrera FJ, Montero L, Morchón D, Díez J, Soriano JB, et al. Comorbidity and gender-related differences in patients hospitalized for COPD. The ECCO study. Respir Med. 2010;104:253–259. doi:10.1016/j.rmed.2009.09.019.
  • Wandell PE, Gafvels C. Patients with type 2 diabetes aged 35-64 years at four Primary Health Care Centres in Stockholm county, Sweden. prevalence and complications in relation to gender and socio-economic status. Diabetes Res Clin Pract. 2004;63:195–203.
  • Gale EA, Gillespie KM. Diabetes and gender. Diabetologia. 2001;44:3–15. doi:10.1007/s001250051573.
  • Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J. 2008;32:962–969. doi:10.1183/09031936.00012408.
  • Lin C-S, Liu C-C, Yeh C-C, Chang Y-C, Chung C-L, Lane H-L, Shih C-C, et al. Diabetes risks and outcomes in chronic obstructive pulmonary disease patients: two nationwide population-based retrospective cohort studies. PLoS One. 2017;12:e0181815. doi:10.1371/journal.pone.0181815.
  • Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. Jama. 2001;286:327–334.
  • Sevenoaks MJ, Stockley RA. Chronic obstructive pulmonary disease, inflammation and co-morbidity–a common inflammatory phenotype? Respir Res. 2006;7:70.
  • Leuppi JD, Schuetz P, Bingisser R, Bodmer M, Briel M, Drescher T, Duerring U, et al. Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. Jama. 2013;309:2223–2231. doi:10.1001/jama.2013.5023.
  • Groenewegen KH, Schols AM, Wouters EF. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest. 2003;124:459–467. doi:10.1378/chest.124.2.459.
  • Duma D, Collins JB, Chou JW, Cidlowski JA. Sexually dimorphic actions of glucocorticoids provide a link to inflammatory diseases with gender differences in prevalence. Sci Signal. 2010;3:ra74. doi:10.1126/scisignal.2001077.
  • Noda T, Ojima T, Hayasaka S, Hagihara A, Takayanagi R, Nobutomo K. The health impact of remarriage behavior on chronic obstructive pulmonary disease: findings from the US longitudinal survey. BMC Public Health. 2009;9:412. doi:10.1186/1471-2458-9-412.
  • Joung IM, van de Mheen HD, Stronks K, van Poppel FW, Mackenbach JP. A longitudinal study of health selection in marital transitions. Soc Sci Med. 1998;46:425–435.
  • Gao Z, Dosman JA, Rennie DC, Schwartz DA, Yang IV, Beach J, Senthilselvan A, et al. Gender-specific associations between polymorphisms in the toll-like receptor (TLR) genes and lung function among workers in swine operations. J Toxicol Environ Health A. 2018;81:1186–1198. doi:10.1080/15287394.2018.1544523.
  • Lange P, Parner J, Prescott E, Ulrik CS, Vestbo J. Exogenous female sex steroid hormones and risk of asthma and asthma-like symptoms: a cross sectional study of the general population. Thorax. 2001;56:613–616. doi:10.1136/thorax.56.8.613.
  • Brzostek D, Kokot M. Asthma-chronic obstructive pulmonary disease overlap syndrome in Poland. findings of an epidemiological study. Postepy Dermatol Alergol. 2014;31:372–379. doi:10.5114/pdia.2014.47120.
  • Cataldo D, Corhay JL, Derom E, Louis R, Marchand E, Michils A, Ninane V, et al. A belgian survey on the diagnosis of asthma-COPD overlap syndrome. Int J Chron Obstruct Pulmon Dis 2017;12:601–613. doi:10.2147/COPD.S124459.
  • Kendzerska T, Sadatsafavi M, Aaron SD, To TM, Lougheed MD, FitzGerald JM, Gershon AS, et al. Concurrent physician-diagnosed asthma and chronic obstructive pulmonary disease: a population study of prevalence, incidence and mortality. PLoS One. 2017;12:e0173830. doi:10.1371/journal.pone.0173830.
  • Jenkins MA, Clarke JR, Carlin JB, Robertson CF, Hopper JL, Dalton MF, Holst DP, et al. Validation of questionnaire and bronchial hyperresponsiveness against respiratory physician assessment in the diagnosis of asthma. Int J Epidemiol. 1996;25:609–616. doi:10.1093/ije/25.3.609.
  • Bird Y, Moraros J, Mahmood R, Esmaeelzadeh S, Kyaw Soe NM. Prevalence and associated factors of COPD among aboriginal peoples in Canada: a cross-sectional study. Int J Chron Obstruct Pulmon Dis 2017;12:1915–1922. doi:10.2147/COPD.S138304.
  • Toren K, Brisman J, Jarvholm B. Asthma and asthma-like symptoms in adults assessed by questionnaires. A literature review. Chest. 1993;104:600–608. doi:10.1378/chest.104.2.600.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.